You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 23 No. 6, December 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (21)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Control of Glycogen Metabolism in Human Muscle

Evidence From Glycogen Storage Diseases

Salvatore DiMauro, MD; Lewis P. Rowland, MD; Paola M. DiMauro, PhD

Arch Neurol. 1970;23(6):534-540.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

LITTLE is known of the mechanisms that control the resting level of glycogen in either normal or pathological human muscle. Animal studies, however, suggest that the polysaccharide itself plays a role in the regulation of its own metabolism by influencing the proportion of active and inactive forms of glycogen synthetase, the principal synthetic enzyme,1 so that increased tissue levels of glycogen retard synthesis of the polysaccharide. Glycogen inhibits the phosphatase that converts the dependent (D) form of synthetase to the presumably more active independent (I) form.2 Similarly, the principal degradative enzyme, phosphorylase, exists in active and inactive forms that are also modified by glycogen. High tissue levels of the polysaccharide increase the proportion of active phosphorylase a at the expense of the inactive phosphorylase b,3 primarily through effects on a separate enzyme, phosphorylase b kinase, that catalyzes the conversion of phosphorylase b to a.4 . . . [Full Text PDF of this Article]


Author Affiliations

Philadelphia

From the Neurological Clinical Research Center and the Spiller Neurological Unit, Hospital of the University of Pennsylvania, Philadelphia.


Footnotes

Accepted for publication July 6, 1970.

Reprint requests to Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia 19104 (Dr. Rowland).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.